A detailed history of Invesco Ltd. transactions in Cassava Sciences Inc stock. As of the latest transaction made, Invesco Ltd. holds 14,771 shares of SAVA stock, worth $392,465. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,771
Previous 14,217 3.9%
Holding current value
$392,465
Previous $288,000 36.81%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$12.35 - $26.11 $6,841 - $14,464
554 Added 3.9%
14,771 $182,000
Q1 2024

May 14, 2024

SELL
$18.44 - $26.41 $1.13 Million - $1.62 Million
-61,275 Reduced 81.17%
14,217 $288,000
Q4 2023

Feb 12, 2024

BUY
$12.64 - $30.11 $741,702 - $1.77 Million
58,679 Added 349.01%
75,492 $1.7 Million
Q3 2023

Nov 13, 2023

SELL
$16.64 - $25.32 $5,940 - $9,039
-357 Reduced 2.08%
16,813 $279,000
Q2 2023

Aug 11, 2023

SELL
$21.59 - $27.88 $6.01 Million - $7.76 Million
-278,452 Reduced 94.19%
17,170 $421,000
Q1 2023

May 12, 2023

SELL
$23.46 - $36.44 $2.92 Million - $4.54 Million
-124,668 Reduced 29.66%
295,622 $7.13 Million
Q4 2022

Feb 13, 2023

BUY
$27.82 - $44.16 $4.57 Million - $7.25 Million
164,203 Added 64.12%
420,290 $12.4 Million
Q3 2022

Nov 14, 2022

BUY
$16.33 - $51.06 $3.92 Million - $12.3 Million
240,355 Added 1527.81%
256,087 $10.7 Million
Q2 2022

Aug 15, 2022

SELL
$17.22 - $38.47 $8,420 - $18,811
-489 Reduced 3.01%
15,732 $442,000
Q1 2022

May 16, 2022

SELL
$32.6 - $53.05 $11,149 - $18,143
-342 Reduced 2.06%
16,221 $602,000
Q4 2021

Feb 14, 2022

SELL
$36.77 - $90.91 $58,023 - $143,455
-1,578 Reduced 8.7%
16,563 $723,000
Q3 2021

Nov 15, 2021

SELL
$41.79 - $135.3 $6.47 Million - $21 Million
-154,923 Reduced 89.52%
18,141 $1.13 Million
Q2 2021

Aug 17, 2021

BUY
$32.15 - $89.72 $4.94 Million - $13.8 Million
153,686 Added 793.1%
173,064 $14.8 Million
Q1 2021

May 17, 2021

BUY
$7.09 - $87.95 $49,069 - $608,701
6,921 Added 55.56%
19,378 $871,000
Q4 2020

Feb 16, 2021

BUY
$6.79 - $12.25 $84,583 - $152,598
12,457 New
12,457 $85,000

Others Institutions Holding SAVA

About CASSAVA SCIENCES INC


  • Ticker SAVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,097,900
  • Market Cap $1.07B
  • Description
  • Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...
More about SAVA
Track This Portfolio

Track Invesco Ltd. Portfolio

Follow Invesco Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.